| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 180.74B | 185.75B | 176.12B | 166.32B | 182.77B | 172.63B |
| Gross Profit | 24.33B | 25.86B | 23.38B | 20.45B | 21.68B | 20.22B |
| EBITDA | 2.57B | 2.88B | 2.52B | 2.69B | 3.82B | 3.45B |
| Net Income | 1.64B | 2.14B | 1.60B | 2.49B | 2.98B | 2.29B |
Balance Sheet | ||||||
| Total Assets | 89.36B | 95.96B | 89.47B | 76.18B | 78.45B | 75.83B |
| Cash, Cash Equivalents and Short-Term Investments | 19.21B | 13.82B | 17.26B | 15.10B | 12.10B | 10.93B |
| Total Debt | 13.96B | 9.69B | 13.69B | 4.79B | 5.26B | 3.44B |
| Total Liabilities | 65.78B | 70.95B | 66.17B | 53.75B | 57.84B | 57.66B |
| Stockholders Equity | 23.49B | 24.92B | 23.23B | 22.42B | 20.60B | 18.16B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.87B | 2.18B | 2.86B | 50.00M | 1.31B |
| Operating Cash Flow | 0.00 | 3.56B | 2.30B | 3.07B | 2.74B | 2.64B |
| Investing Cash Flow | 0.00 | -490.00M | -2.19B | 1.06B | -2.67B | -1.01B |
| Financing Cash Flow | 0.00 | -5.13B | 1.92B | -1.10B | 1.18B | -1.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥61.89B | 6.94 | ― | 3.25% | 15.03% | 223.61% | |
70 Outperform | ¥11.61B | 7.14 | ― | 3.21% | 1.16% | 122.45% | |
68 Neutral | ¥12.31B | 26.61 | ― | 1.24% | 5.74% | 10.43% | |
65 Neutral | ¥466.78B | 15.36 | 7.93% | 2.32% | 0.24% | -54.29% | |
62 Neutral | ¥19.72B | 9.08 | ― | 3.07% | 5.47% | 33.42% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | ¥18.40B | 38.48 | ― | 3.24% | -6.49% | ― |